ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,693Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 103

$792K Total Retail Price of All Prescriptions

Rank: 8 out of 103

481 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,754 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 542 507 1 1
AMLODIPINE BESYLATE 501 497 2 6
SIMVASTATIN 424 375 3 2
WARFARIN SODIUM 349 347 4 7
OMEPRAZOLE 309 289 5 3
LISINOPRIL 304 284 6 5
LOSARTAN POTASSIUM 278 277 7 12
POTASSIUM CHLORIDE 254 227 8 10
METFORMIN HCL 213 189 9 13
SYNTHROID 205 185 10 51
GABAPENTIN 204 184 11 22
CITALOPRAM HBR 203 188 12 15
METOPROLOL SUCCINATE 199 192 13 8
ATENOLOL 160 156 14 14
METOPROLOL TARTRATE 156 146 15 9
ATORVASTATIN CALCIUM 154 152 16 18
TAMSULOSIN HCL 147 125 17 23
FUROSEMIDE 142 133 18 4
NAMENDA 140 140 19 41
TRAMADOL HCL 130 123 20 17
ZETIA 128 128 21 66
HYDROCHLOROTHIAZIDE 122 120 22 16
CARVEDILOL 119 115 23 20
TRAZODONE HCL 117 101 24 52
ALLOPURINOL 111 111 25 26
CRESTOR 110 110 26 27
ALENDRONATE SODIUM 107 95 27 19
DONEPEZIL HCL 106 106 28 28
EXELON 104 104 29 124
DIGOXIN 99 88 30 25
PRAVASTATIN SODIUM 98 79 31 33
OXYCONTIN 86 85 S2 32 140
BYSTOLIC 84 84 33 99
ZOLPIDEM TARTRATE 81 74 34 29
SERTRALINE HCL 79 78 35 21
SPIRONOLACTONE 78 73 36 30
NEXIUM 71 65 37 43
HYDROCODONE-ACETAMINOPHEN 71 49 S3 37 11
CLOPIDOGREL 70 61 39 32
BUMETANIDE 68 68 40 132
CARBIDOPA-LEVODOPA 66 66 41 55
PLAVIX 61 51 42 46
POLYETHYLENE GLYCOL 3350 61 61 42 31
SPIRIVA 59 58 44 64
GEMFIBROZIL 58 57 45 62
ADVAIR DISKUS 57 56 46 42
IPRATROPIUM BROMIDE 56 56 47 128
LOSARTAN-HYDROCHLOROTHIAZIDE 55 38 48 47
PAROXETINE HCL 54 54 49 81
ENALAPRIL MALEATE 54 54 49 63
BUSPIRONE HCL 54 36 49 227
PREDNISONE 54 45 49 24
LANTUS SOLOSTAR 54 46 49 97
ESCITALOPRAM OXALATE 52 50 54 73
LANTUS 52 45 54 39
CLONIDINE HCL 52 52 54 82
OXYCODONE HCL 51 51 S2 57 85
VYTORIN 50 50 58 155
AVODART 50 50 58 115
HUMALOG 50 50 58 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.